GO:0008250 oligosaccharyltransferase complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008250 describes the oligosaccharyltransferase (OST) complex, a multi-subunit enzyme in the endoplasmic reticulum membrane that transfers lipid-linked oligosaccharides to asparagine residues on nascent proteins.
• The OST complex contains at least eight non-identical subunits, and mammals express distinct OST isoforms (OST-A, OST-B, OST-C) with different catalytic and accessory subunits.
• OST-mediated N-glycosylation is essential for protein folding, quality control, and trafficking, and its disruption affects chaperone function and receptor transport.
• The OST complex is a validated therapeutic target: inhibition treats prion disease in rodent and human models, and a druggable pocket in an OST subunit is required for inflammatory NF-kB signaling.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable precise interrogation of OST subunit function in human cells.
• Researchers studying OST biology use CRISPR screens, proteomics, imaging, and glycosylation assays to dissect subunit-specific roles and disease connections.
Description
The oligosaccharyltransferase (OST) complex, annotated as GO:0008250, is a conserved multi-subunit enzyme embedded in the endoplasmic reticulum (ER) membrane that catalyzes the transfer of a lipid-linked oligosaccharide precursor to asparagine residues within the sequon Asn-X-Ser/Thr of nascent polypeptides. This co-translational modification, known as N-glycosylation, is one of the most abundant protein modifications in eukaryotes and is essential for protein folding, stability, and trafficking. The OST complex includes at least eight non-identical subunits, and in mammals, different forms of the complex containing distinct subunits have been detected, generating functional diversity. For researchers, GO:0008250 represents a central node in ER biology and a promising therapeutic target. Recent studies have shown that regulated N-glycosylation by OST controls chaperone function and receptor trafficking, and that OST inhibition effectively treats rodent and human prions. Moreover, positive selection CRISPR screens have revealed a druggable pocket in an OST subunit required for inflammatory signaling to NF-kB. These findings underscore the importance of understanding OST composition, assembly, and regulation at molecular resolution. This article provides a research-grade overview of the OST complex, covering its definition, structure, catalytic mechanism, key genes, disease links, and experimental models. All statements are grounded in published literature and the QuickGO definition, with citations to verified PMIDs.
oligosaccharyltransferase complex At A Glance
| GO ID | GO:0008250 |
|---|---|
| GO term | oligosaccharyltransferase complex |
| Ontology | cellular_component |
| Synonym | oligosaccharyl transferase complex; OSTCI; OSTCII; OSTCIII; OST complex |
| Major function | Transfers lipid-linked oligosaccharide precursor to asparagine residues on nascent proteins in the ER membrane |
| Subunit composition | At least eight non-identical subunits; distinct subunit isoforms in mammals |
| Localization | Endoplasmic reticulum membrane |
| Catalytic mechanism | En bloc transfer of Glc3Man9GlcNAc2 from dolichol-linked donor to Asn-X-Ser/Thr sequons |
| Disease relevance | Prion disease, inflammatory signaling, cancer, and congenital disorders of glycosylation |
What Is GO:0008250?
GO:0008250 (oligosaccharyltransferase complex) is defined as a protein complex found in the endoplasmic reticulum membrane of eukaryotes that transfers lipid-linked oligosaccharide precursors to asparagine residues on nascent proteins. The complex includes at least eight non-identical subunits, and different forms containing distinct subunits have been detected in mammals. Synonyms include oligosaccharyl transferase complex, OSTCI, OSTCII, OSTCIII, and OST complex.
Why Is oligosaccharyltransferase complex Important in Cell Biology?
The OST complex is essential for N-glycosylation, a fundamental co-translational modification that affects nearly all secreted and membrane proteins. Proper N-glycosylation is required for protein folding, quality control, and trafficking, and its dysregulation is linked to a growing list of human diseases, including prion disorders, inflammatory conditions, and cancer. Understanding OST subunit composition and regulation provides mechanistic insights into ER homeostasis and offers opportunities for therapeutic intervention.
• Catalyzes the central step of N-glycosylation, affecting protein folding and stability.
• Contains multiple subunits with distinct roles, enabling functional specialization.
• Regulated N-glycosylation controls chaperone function and receptor trafficking.
• OST inhibition is a promising strategy for treating prion diseases.
• A druggable pocket in an OST subunit is required for inflammatory NF-kB signaling.
• OST genes are essential in human cells, as shown by haploid genetic screens.
• Visualization of translation and protein biogenesis at the ER membrane reveals OST dynamics.
• The OST complex is conserved across eukaryotes, including Plasmodium species.
• Dysregulation of OST subunits is implicated in cancer and congenital disorders of glycosylation.
• CRISPR screens identify OST components as vulnerabilities in specific cellular contexts.
What Happens During oligosaccharyltransferase complex?
Recognition of the N-glycosylation sequon
In simple terms: The OST complex scans new proteins for a specific three-amino-acid tag.
The OST complex recognizes the sequon Asn-X-Ser/Thr (where X is any amino acid except Pro) on nascent polypeptides as they emerge from the ribosome and enter the ER lumen. This recognition is mediated by the catalytic subunit STT3, which binds the acceptor asparagine and the lipid-linked oligosaccharide donor. The sequon must be accessible and properly positioned for efficient transfer.
Transfer of the lipid-linked oligosaccharide
In simple terms: The complex snips a sugar tree from a lipid carrier and attaches it to the protein.
The OST complex catalyzes the en bloc transfer of the preassembled oligosaccharide Glc3Man9GlcNAc2 from the dolichol-linked donor to the asparagine residue of the sequon. This reaction occurs in the ER membrane and requires the coordinated action of multiple subunits, including STT3, which contains the catalytic site. The transfer is essential for subsequent glycan processing and protein folding.
Subunit-specific functions and isoform diversity
In simple terms: Different versions of the complex do slightly different jobs.
Mammalian OST complexes exist in at least three isoforms (OST-A, OST-B, OST-C) defined by distinct catalytic and accessory subunits, such as STT3A versus STT3B, and different OST4, OST48, and other subunits. These isoforms exhibit preferences for co-translational versus post-translational glycosylation and for specific sequon contexts. This diversity allows fine-tuning of N-glycosylation across different proteins and cellular conditions.
Coupling to protein translocation and folding
In simple terms: The sugar attachment is timed with protein entry into the ER and folding.
The OST complex physically associates with the translocon and other ER machinery to couple glycosylation with protein translocation and folding. Visualization studies have shown that translation and protein biogenesis at the ER membrane are spatially organized, with OST positioned to act on nascent chains. This coupling ensures that N-glycosylation occurs co-translationally and supports proper folding and quality control.
Key Genes Involved in GO:0008250 oligosaccharyltransferase complex
The following genes encode subunits of the oligosaccharyltransferase complex and related proteins, with roles in N-glycosylation and ER biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STT3A | Catalytic subunit of OST-A isoform; transfers glycan to nascent proteins | Essential for co-translational glycosylation; target in CRISPR screens |
| STT3B | Catalytic subunit of OST-B isoform; post-translational glycosylation | Important for sequon skipping and quality control |
| RPN1 | Accessory subunit; binds dolichol-linked oligosaccharide | Modulates OST activity and substrate selection |
| RPN2 | Accessory subunit; stabilizes complex and binds ribosome | Required for efficient glycosylation |
| OST4 | Small subunit; essential for complex assembly | Mutations affect OST stability and function |
| DDOST (OST48) | Accessory subunit; links catalytic and regulatory subunits | Implicated in congenital disorders of glycosylation |
| MAGT1 | Subunit of OST-C; involved in immune function | Defects cause immunodeficiency and glycosylation abnormalities |
| TUSC3 | Subunit of OST-B; tumor suppressor candidate | Loss associated with cancer and glycosylation defects |
| KRTCAP2 | Accessory subunit; keratinocyte-associated | Role in OST assembly and skin biology |
| TMEM258 | Subunit of OST complex; ER membrane protein | Regulates inflammatory signaling and NF-kB |
| DAD1 | Defender against apoptotic death; OST subunit | Apoptosis regulation and complex stability |
| OSTC | Subunit of OST complex; conserved in eukaryotes | Required for catalytic activity |
| STT3 | Catalytic subunit in Plasmodium and other eukaryotes | Target for antimalarial drug development |
| SEC61A1 | Translocon subunit; interacts with OST | Couples translocation and glycosylation |
| RPL4 | Ribosomal protein; docks OST at ER | Facilitates co-translational glycosylation |
| NGLY1 | Peptide:N-glycanase; degrades misfolded glycoproteins | Links OST to ER-associated degradation |
| UGGT1 | UDP-glucose:glycoprotein glucosyltransferase; folding sensor | Works with OST in glycoprotein quality control |
| CALR | Calreticulin; lectin chaperone | Binds monoglucosylated glycans generated after OST action |
How Is oligosaccharyltransferase complex Regulated?
The OST complex is regulated at multiple levels. Regulated N-glycosylation controls chaperone function and receptor trafficking, indicating dynamic modulation of OST activity. The complex interacts with the translocon and ribosome, and its subunit composition can shift in response to cellular stress or differentiation. Additionally, positive selection CRISPR screens have identified a druggable pocket in an OST subunit that is required for inflammatory signaling to NF-kB, suggesting that OST activity can be pharmacologically modulated. In Plasmodium, OST subunits are differentially expressed across life stages, highlighting developmental regulation.
oligosaccharyltransferase complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STT3A | Cancer, glycosylation defects | CRISPR knockout in cancer cell lines; xenograft models |
| STT3B | Prion disease, viral infection | Knockout mice; prion-infected cells |
| DDOST | Congenital disorder of glycosylation | Patient-derived fibroblasts; knock-in mouse models |
| MAGT1 | Immunodeficiency, EBV susceptibility | Lymphoblastoid cell lines; CRISPR correction |
| TMEM258 | Inflammatory bowel disease, NF-kB signaling | Intestinal organoids; knockout mice |
Prion diseases
Oligosaccharyltransferase (OST) complex inhibition effectively treats rodent and human prions, demonstrating that targeting N-glycosylation can reduce prion propagation and neurotoxicity. This suggests OST as a therapeutic target for neurodegenerative prion disorders.
Inflammatory signaling and cancer
A druggable pocket in an oligosaccharyltransferase subunit is required for inflammatory signaling to NF-kB, linking OST activity to inflammation and cancer. Positive selection CRISPR screens have revealed that OST components are essential in specific cancer cell contexts, and their inhibition may sensitize tumors to therapy.
Congenital disorders of glycosylation
Mutations in OST subunit genes, such as DDOST and MAGT1, cause congenital disorders of glycosylation with multisystem phenotypes, including immunodeficiency and developmental delay. These disorders highlight the non-redundant roles of individual OST subunits in human health.
From oligosaccharyltransferase complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is STT3A essential for co-translational glycosylation? | CRISPR knockout of STT3A in HEK293T cells followed by glycoproteomics |
| Does a point mutation in the catalytic site abolish OST activity? | CRISPR point mutation (e.g., STT3A DxxxA) knock-in cell lines |
| How does OST subunit composition affect receptor trafficking? | Knock-in of tagged subunits (e.g., STT3A-HA) for imaging and proteomics |
| Can OST overexpression rescue glycosylation defects? | Overexpression of STT3A or STT3B in patient fibroblasts |
| What is the role of OST in inflammatory signaling? | CRISPR knockout of TMEM258 in macrophages followed by NF-kB reporter assays |
| Is OST a therapeutic target for prion disease? | Treatment of prion-infected cells and mice with OST inhibitors |
How to Study the oligosaccharyltransferase complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screens | Gene essentiality and synthetic lethality | Identify OST subunits required for cancer cell growth |
| Glycoproteomics (LC-MS/MS) | Site-specific N-glycosylation occupancy | Assess OST activity and subunit specificity |
| Cryo-electron tomography | Spatial organization of ER translation machinery | Visualize OST-translocon-ribosome coupling |
| Fluorescence microscopy | Subcellular localization and trafficking | Track OST subunits and cargo receptors |
| Co-immunoprecipitation | Protein-protein interactions | Map OST subunit interactions |
| In vitro glycosylation assay | Enzymatic transfer activity | Measure catalytic function of OST subunits |
| RNA-seq | Transcriptional changes upon OST perturbation | Identify compensatory pathways |
| CRISPR point mutation knock-in | Specific amino acid function | Test catalytic residues in STT3A |
CRISPR screening for OST vulnerabilities
Positive selection CRISPR screens can identify OST subunits required for specific cellular processes, such as inflammatory signaling or survival under stress. These screens use genome-wide or focused libraries to knock out genes and select for phenotypes, revealing essential and context-dependent roles of OST components.
Glycoproteomics and mass spectrometry
Mass spectrometry-based glycoproteomics enables site-specific mapping of N-glycosylation on nascent proteins, allowing assessment of OST activity and subunit specificity. This method can quantify changes in glycosylation upon OST perturbation.
Imaging and structural biology
Cryo-electron tomography and fluorescence imaging have visualized translation and protein biogenesis at the ER membrane, revealing the spatial organization of OST relative to the translocon and ribosome. These approaches provide mechanistic insights into co-translational glycosylation.
Genetic and biochemical assays
Yeast and mammalian genetic systems, including haploid human cell screens, have been used to dissect OST subunit essentiality and synthetic lethality. Biochemical assays with dolichol-linked oligosaccharide donors measure catalytic activity of purified or reconstituted OST complexes.
How CRISPR Can Be Used to Study GO:0008250 oligosaccharyltransferase complex
Knockout
CRISPR knockout of OST subunit genes (e.g., STT3A, STT3B, DDOST) in human cell lines abolishes or reduces N-glycosylation, leading to protein misfolding and ER stress. These models are used to study subunit essentiality and identify synthetic lethal interactions.
Point Mutation
CRISPR point mutation knock-in can introduce catalytic-dead mutations (e.g., in the STT3A active site) to dissect enzymatic versus structural functions of OST subunits. Such models help distinguish glycosylation-dependent and independent roles.
Knock-in
Tagged knock-in of OST subunits (e.g., STT3A-HA or STT3B-GFP) enables live-cell imaging, proteomics, and proximity labeling to study complex assembly and dynamics. Knock-in of disease-associated mutations models congenital disorders of glycosylation.
Overexpression
Overexpression of OST subunits (e.g., STT3A or STT3B) can rescue glycosylation defects in patient cells or enhance glycosylation capacity for biotherapeutic production. Overexpression models are also used to study dominant-negative effects.
How EDITGENE Supports oligosaccharyltransferase complex Research
Researchers studying oligosaccharyltransferase complex-related genes often need to determine whether a candidate gene is causally involved in glycosylation, ER homeostasis, or disease. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for functional validation.
Contact EDITGENE today to design your custom CRISPR model for oligosaccharyltransferase complex research.
Frequently Asked Questions About oligosaccharyltransferase complex
What is the oligosaccharyltransferase complex?
The oligosaccharyltransferase (OST) complex is a multi-subunit enzyme in the endoplasmic reticulum membrane that transfers lipid-linked oligosaccharides to asparagine residues on nascent proteins, as defined by GO:0008250.
What genes are involved in the oligosaccharyltransferase complex?
Key genes include STT3A, STT3B, RPN1, RPN2, OST4, DDOST, MAGT1, TUSC3, KRTCAP2, TMEM258, DAD1, and OSTC, which encode subunits of the complex.
What is the function of GO:0008250?
GO:0008250 describes the molecular function of the OST complex in catalyzing N-glycosylation, a co-translational modification essential for protein folding and trafficking.
How is the oligosaccharyltransferase complex regulated?
OST activity is regulated by subunit composition, interaction with the translocon and ribosome, and cellular stress, with distinct isoforms in mammals.
What diseases are associated with oligosaccharyltransferase complex dysfunction?
Dysfunction is linked to prion diseases, inflammatory disorders, cancer, and congenital disorders of glycosylation.
Can CRISPR be used to study the oligosaccharyltransferase complex?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise interrogation of OST subunit function in human cells.
What are the subunits of the oligosaccharyltransferase complex?
The complex includes at least eight non-identical subunits, such as STT3, RPN1, RPN2, OST4, OST48, DAD1, and others, with isoforms in mammals.
Is the oligosaccharyltransferase complex a drug target?
Yes, OST inhibition treats prion disease in models, and a druggable pocket in an OST subunit is required for inflammatory NF-kB signaling.
How does the oligosaccharyltransferase complex recognize substrates?
It recognizes the Asn-X-Ser/Thr sequon on nascent polypeptides and transfers a preassembled oligosaccharide from a dolichol carrier.
What methods are used to study the oligosaccharyltransferase complex?
Common methods include CRISPR screens, glycoproteomics, cryo-electron tomography, co-immunoprecipitation, and in vitro glycosylation assays.
Conclusion
The oligosaccharyltransferase complex (GO:0008250) is a central enzyme in N-glycosylation, with essential roles in protein folding, trafficking, and cellular signaling. Its multi-subunit architecture and isoform diversity provide functional specialization, and its dysfunction is linked to prion disease, inflammation, cancer, and congenital disorders. Continued research using CRISPR models and advanced proteomics will further illuminate OST biology and therapeutic potential.
References
- 1. Yan Q et al.. 1999. Oligosaccharyltransferase: a complex multisubunit enzyme of the endoplasmic reticulum.. Biochem Biophys Res Commun 266(3):684-9 PMID: 10603306
- 2. Ma M et al.. 2024. Regulated N-glycosylation controls chaperone function and receptor trafficking.. Science 386(6722):667-672 PMID: 39509507
- 3. Knauer R et al.. 1999. The oligosaccharyltransferase complex from yeast.. Biochim Biophys Acta 1426(2):259-73 PMID: 9878773
- 4. Beauchemin KS et al.. 2026. Oligosaccharyltransferase (OST) complex inhibition effectively treats rodent and human prions.. PLoS Pathog 22(1):e1013867 PMID: 41525337
- 5. Lampson BL et al.. 2024. Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κB.. Cell 187(9):2209-2223.e16 PMID: 38670073
- 6. Blomen VA et al.. 2015. Gene essentiality and synthetic lethality in haploid human cells.. Science 350(6264):1092-6 PMID: 26472760
- 7. Gemmer M et al.. 2023. Visualization of translation and protein biogenesis at the ER membrane.. Nature 614(7946):160-167 PMID: 36697828
- 8. Tamana S et al.. 2019. An updated view of the oligosaccharyltransferase complex in Plasmodium.. Glycobiology 29(5):385-396 PMID: 30835280
